Recent Publications from the Kublius Lab

Research Publications Cell Biology


Kubilus JK, Zapater I Morales C, Linsenmayer TF. 2017. The corneal epithelial barrier and its developmental role in isolating corneal epithelial and conjunctival cells from one another. Invest Ophthalmol Vis Sci. 58: 1665-1672. books

Kubilus JK, Beazley KE, Talbot CJ, Linsenmayer TF. 2016. Nuclear ferritin mediated regulation of JNK signaling in corneal epithelial cells. Exp Eye Res. books

Canner JP, Linsenmayer TF, Kubilus JK. 2014. Developmental regulation of trigeminal TRPA1 by the cornea. Invest Ophthalmol Vis Sci. 56: 29-36. books

Kubilus JK, Linsenmayer TF. 2010. Developmental guidance of embryonic corneal innervation: Roles of Semaphorin3A and Slit2. Dev Biol. 344: 172-184. books

Kubilus JK, Linsenmayer TF. 2010. Developmental corneal innervation: interactions between nerves and specialized apical corneal epithelial cells. Invest Ophthalmol Vis Sci. 51: 782-789. books

Bandyopadhyay A, Kubilus JK, Crochiere ML, Linsenmayer TF, Tabin CJ. 2008. Identification of unique molecular subdomains in the perichondrium and periosteum and their role in regulating gene expression in the underlying chondrocytes. Dev Biol. 321: 162-174. books

Crochiere ML, Kubilus JK, Linsenmayer TF. 2008. Perichondrial-mediated TGF-β regulation of cartilage growth in avian long bone development. Int J Dev. 52: 63-70. books

Stack EC, Dedeoglu A, Smith KM, Cormier K, Kubilus JK, Bogdanov M, Matson WR, Yang L, Jenkins BG, Luthi-Carter R, Kowall NW, Hersch SM, Beal MF, Ferrante RJ. 2007. Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice. J Neurosci. 27: 12908-12915. books

Crochiere ML, Kubilus JK, Linsenmayer TF. 2006. Identification and characterization of a previously undetected region between the perichondrium and periosteum of the developing avian limb. Dev Biol. 299: 505-516. books

Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, Ryu H, Langley B, Ratan RR, Ferrante RJ, Beal MF. 2005. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. J Biol Chem. 280: 556-563. books

Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ. 2005. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J Comp Neurol. 490: 354-370. books

Ferrante RJ, Ryu H, Kubilus JK, D'Mello S, Sugars KL, Lee J, Lu P, Smith K, Browne S, Beal MF, Kristal BS, Stavrovskaya IG, Hewett S, Rubinsztein DC, Langley B, Ratan RR. 2004. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. J Neurosci. 24: 10335-10342. books

Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R, Hersch SM. 2003. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci. 23: 9418-9427. books

Dedeoglu A, Kubilus JK, Yang L, Ferrante KL, Hersch SM, Beal MF, Ferrante RJ. 2003. Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice. J Neurochem. 85: 1359-1367. books

Apply to the Sackler School


The priority application deadlines are as follows:

December 1: Basic Science Division PhD Programs

February 15: Building Diversity in Biomedical Sciences

March 31: Post-Baccalaureate Research Program

May 1: Clinical & Translational Science, MS in Pharmacology & Drug Development